Skip to main content
Premium Trial:

Request an Annual Quote

US Genomics Raises $17M in Private Placement

NEW YORK, April 4 – US Genomics of Woburn, Mass., said Wednesday it has raised $17 million in private financing, which will be used to develop the company’s DNA analysis technology.

HealthCare Ventures and existing investors, including CB Health Ventures and Still River Fund, contributed to the financing round. Augustine Lawlor, general partner at HealthCare Ventures, also joined US Genomics’ board of directors.

"US Genomics has created a powerful, fundamental new technology that carries the potential of enabling commercial applications of genetics analysis across a broad range of industries," Lawlor said in a statement.

US Genomics said its technology, which is designed to generate haplotype data, allows researchers to read long stretches of genetic sequence data in a direct, linear fashion. The company plans to eventually use the technology to read whole genomes and to apply it to drug discovery and diagnostics.

A company spokesman was not immediately available to explain how the technology works.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.